Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

"Maybe if I stop the drugs, then maybe they'd care?"-hospital care experiences of people who use drugs.

Chan Carusone S, Guta A, Robinson S, Tan DH, Cooper C, O'Leary B, de Prinse K, Cobb G, Upshur R, Strike C.

Harm Reduct J. 2019 Feb 13;16(1):16. doi: 10.1186/s12954-019-0285-7.

2.

Syphilis co-infection is not associated with an increased risk of virologic failure among HIV-positive men who have sex with men on antiretroviral therapy.

Grewal R, Allen VG, Bayoumi AM, Gardner SL, Kaul R, Mazzulli T, Moravan V, O'neill T, Raboud J, Rourke SB, Tan DH, Burchell AN; Ontario HIV Treatment Network Cohort Study Research Team.

J Acquir Immune Defic Syndr. 2019 Jan 25. doi: 10.1097/QAI.0000000000001962. [Epub ahead of print]

PMID:
30730358
3.

Regio- and Diastereoselective Synthesis of Cyclohexadienylborons via Intermolecular Diels-Alder Reaction of Alkenyl MIDA Boronates with 2-Pyrones.

Wang H, Lv WX, Li Z, Lin E, Li JL, Tan DH, Cai YH, Li Q.

Chemistry. 2019 Jan 29. doi: 10.1002/chem.201900011. [Epub ahead of print]

PMID:
30697832
4.

Acceptability and tolerability of and adherence to HIV preexposure prophylaxis among Toronto gay and bisexual men: a pilot study.

Tan DHS, Schnubb A, Lawless J, Szadkowski L, Grennan T, Wilton J, Fowler S, Hart TA, Maxwell J, Raboud JM.

CMAJ Open. 2018 Dec 10;6(4):E611-E617. doi: 10.9778/cmajo.20180068. Print 2018 Oct-Dec.

5.

Subdural empyema complicated with intracranial hemorrhage in a postradiotherapy nasopharyngeal carcinoma patient: A case report and review of literature.

Chen JC, Tan DH, Xue ZB, Yang SY, Li Y, Lai RL.

World J Clin Cases. 2018 Nov 26;6(14):825-829. doi: 10.12998/wjcc.v6.i14.825.

6.

New Canadian guideline provides evidence-based approach to non-occupational HIV prophylaxis.

O'Donnell S, Tan DHS, Hull MW.

CJEM. 2019 Jan;21(1):21-25. doi: 10.1017/cem.2018.462. Epub 2018 Nov 20.

PMID:
30457087
7.

The Need and Desire for Mental Health and Substance Use-Related Services Among Clients of Publicly Funded Sexually Transmitted Infection Clinics in Vancouver, Canada.

Salway T, Ferlatte O, Shoveller J, Purdie A, Grennan T, Tan DHS, Consolacion T, Rich AJ, Dove N, Samji H, Scott K, Blackwell E, Mirau D, Holgerson N, Wong J, Gilbert M.

J Public Health Manag Pract. 2018 Nov 15. doi: 10.1097/PHH.0000000000000904. [Epub ahead of print]

PMID:
30444755
8.

Feasibility of vitamin D supplementation interventions to mitigate HIV pre-exposure prophylaxis-related bone mineral density loss: a cross-sectional survey.

Wang S, Kortenaar JL, Hull MW, Arbess G, Owen JR, Tan DH.

Patient Prefer Adherence. 2018 Oct 16;12:2197-2204. doi: 10.2147/PPA.S178403. eCollection 2018.

9.

Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial.

Tan DHS, Raboud JM, Szadkowski L, Grinsztejn B, Madruga JV, Figueroa MI, Cahn P, Barton SE, Clarke A, Fox J, Zubyk W, Walmsley SL; VALIDATE Study Group .

J Antimicrob Chemother. 2019 Feb 1;74(2):480-488. doi: 10.1093/jac/dky433.

10.

gem-Difluorination of Alkenyl N-methyliminodiacetyl Boronates: Synthesis of α- and β-Difluorinated Alkylborons.

Lv WX, Li Q, Li JL, Li Z, Lin E, Tan DH, Cai YH, Fan WX, Wang H.

Angew Chem Int Ed Engl. 2018 Dec 10;57(50):16544-16548. doi: 10.1002/anie.201810204. Epub 2018 Nov 12.

PMID:
30358035
11.

How visual memory changes with intervening recall.

Tan DH, Jiang YV.

Q J Exp Psychol (Hove). 2018 Nov 2:1747021818808524. doi: 10.1177/1747021818808524. [Epub ahead of print]

PMID:
30296913
12.

Trends in the awareness, acceptability, and usage of HIV pre-exposure prophylaxis among at-risk men who have sex with men in Toronto.

Rana J, Wilton J, Fowler S, Hart TA, Bayoumi AM, Tan DHS.

Can J Public Health. 2018 Jun;109(3):342-352. doi: 10.17269/s41997-018-0064-3. Epub 2018 Apr 26.

13.

Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol.

Sharma M, Chris A, Chan A, Knox DC, Wilton J, McEwen O, Mishra S, Grace D, Rogers T, Bayoumi AM, Maxwell J, Shahin R, Bogoch I, Gilbert M, Tan DHS.

BMC Health Serv Res. 2018 Jul 3;18(1):513. doi: 10.1186/s12913-018-3324-2.

14.

High prevalence of syndemic health problems in patients seeking post-exposure prophylaxis for sexual exposures to HIV.

Morrison SA, Yoong D, Hart TA, MacPherson P, Bogoch I, Sivarajah V, Gough K, Naccarato M, Tan DHS.

PLoS One. 2018 May 23;13(5):e0197998. doi: 10.1371/journal.pone.0197998. eCollection 2018.

15.

Synthesis of α-CF3 and α-CF2H amines via the aminofluorination of fluorinated alkenes.

Yang L, Fan WX, Lin E, Tan DH, Li Q, Wang H.

Chem Commun (Camb). 2018 Jun 5;54(46):5907-5910. doi: 10.1039/c8cc03364a.

PMID:
29789842
16.

Economic evaluation of HIV pre-exposure prophylaxis strategies: protocol for a methodological systematic review and quantitative synthesis.

Thavorn K, Kugathasan H, Tan DHS, Moqueet N, Baral SD, Skidmore B, MacFadden D, Simkin A, Mishra S.

Syst Rev. 2018 Mar 15;7(1):47. doi: 10.1186/s13643-018-0710-0. Review.

17.

High HIV risk and syndemic burden regardless of referral source among MSM screening for a PrEP demonstration project in Toronto, Canada.

Wilton J, Noor SW, Schnubb A, Lawless J, Hart TA, Grennan T, Fowler S, Maxwell J, Tan DHS.

BMC Public Health. 2018 Feb 27;18(1):292. doi: 10.1186/s12889-018-5180-8.

18.

The two processes underlying the testing effect- Evidence from Event-Related Potentials (ERPs).

Liu XL, Tan DH, Reder LM.

Neuropsychologia. 2018 Apr;112:77-85. doi: 10.1016/j.neuropsychologia.2018.02.022. Epub 2018 Feb 21.

PMID:
29474894
19.

Brief Report: HIV Postexposure Prophylaxis-in-Pocket ("PIP") for Individuals With Low-Frequency, High-Risk HIV Exposures.

Tumarkin E, Heendeniya A, Murphy P, Placido T, Tan DHS, Bogoch II.

J Acquir Immune Defic Syndr. 2018 May 1;78(1):20-22. doi: 10.1097/QAI.0000000000001639.

PMID:
29419570
20.

Combination Therapy with Tenofovir Disoproxil Fumarate/Emtricitabine/Elvitegravir/Cobicistat Plus Darunavir Once Daily in Antiretroviral-Naive and Treatment-Experienced Patients: A Retrospective Review.

Naccarato MJ, Yoong DM, Fong IW, Gough KA, Ostrowski MA, Tan DHS.

J Int Assoc Provid AIDS Care. 2018 Jan-Dec;17:2325957417752260. doi: 10.1177/2325957417752260.

PMID:
29385867
21.

Endocarditis in the setting of IDU: multidisciplinary management.

Yanagawa B, Bahji A, Lamba W, Tan DH, Cheema A, Syed I, Verma S.

Curr Opin Cardiol. 2018 Mar;33(2):140-147. doi: 10.1097/HCO.0000000000000493.

PMID:
29232248
22.

The Pre-Exposure Prophylaxis-Stigma Paradox: Learning from Canada's First Wave of PrEP Users.

Grace D, Jollimore J, MacPherson P, Strang MJP, Tan DHS.

AIDS Patient Care STDS. 2018 Jan;32(1):24-30. doi: 10.1089/apc.2017.0153. Epub 2017 Nov 29.

23.

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.

Tan DHS, Hull MW, Yoong D, Tremblay C, O'Byrne P, Thomas R, Kille J, Baril JG, Cox J, Giguere P, Harris M, Hughes C, MacPherson P, O'Donnell S, Reimer J, Singh A, Barrett L, Bogoch I, Jollimore J, Lambert G, Lebouche B, Metz G, Rogers T, Shafran S; Biomedical HIV Prevention Working Group of the CIHR Canadian HIV Trials Network.

CMAJ. 2017 Nov 27;189(47):E1448-E1458. doi: 10.1503/cmaj.170494. No abstract available. Erratum in: CMAJ. 2018 Jun 25;190(25):E782.

24.

Stereoselective Direct Chlorination of Alkenyl MIDA Boronates: Divergent Synthesis of E and Z α-Chloroalkenyl Boronates.

Zeng YF, Ji WW, Lv WX, Chen Y, Tan DH, Li Q, Wang H.

Angew Chem Int Ed Engl. 2017 Nov 13;56(46):14707-14711. doi: 10.1002/anie.201709070. Epub 2017 Oct 17.

PMID:
28963766
25.

Considerations for Using the HIRI-MSM Screening Tool to Identify MSM Who Would Benefit Most From PrEP.

Wilton J, Mishra S, Tan DHS.

J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):e58-e61. doi: 10.1097/QAI.0000000000001472. No abstract available.

PMID:
28903127
26.

PrEP on demand or every day?

Tan DH.

Lancet HIV. 2017 Sep;4(9):e379-e380. doi: 10.1016/S2352-3018(17)30088-7. Epub 2017 Jul 23. No abstract available.

PMID:
28747273
27.

Does maternal HSV-2 coinfection increase mother-to-child transmission of HIV? A systematic review.

Sivarajah V, Venus K, Yudin MH, Murphy KE, Morrison SA, Tan DH.

Sex Transm Infect. 2017 Dec;93(8):535-542. doi: 10.1136/sextrans-2016-052921. Epub 2017 Jun 9. Review.

28.

How memory is tested influences what is measured: Reply to Wyble and Chen (2017).

Swallow KM, Jiang YV, Tan DH.

J Exp Psychol Learn Mem Cogn. 2017 Jun;43(6):1001-1003. doi: 10.1037/xlm0000362.

PMID:
28557487
29.

Cytotoxic triterpenes from the acid hydrolyzate of Gynostemma pentaphyllum saponins.

Shi L, Tan DH, Yan TC, Jiang DH, Hou MX.

J Asian Nat Prod Res. 2018 Feb;20(2):182-187. doi: 10.1080/10286020.2017.1322070. Epub 2017 May 2.

PMID:
28463530
30.

Multidrug-Resistant HIV-1 Infection despite Preexposure Prophylaxis.

Knox DC, Anderson PL, Harrigan PR, Tan DH.

N Engl J Med. 2017 Feb 2;376(5):501-502. doi: 10.1056/NEJMc1611639. No abstract available.

31.

Direct Assembly of Prenylated Heteroarenes through a Cascade Minisci Reaction/Dehydration Sequence.

Tan DH, Zeng YF, Liu Y, Lv WX, Li Q, Wang H.

ChemistryOpen. 2016 Oct 11;5(6):535-539. doi: 10.1002/open.201600096. eCollection 2016 Dec.

32.

Novel imaging modalities for the comparison of bone microarchitecture among HIV+ patients with and without fractures: a pilot study.

Tan DH, Raboud J, Szadkowski L, Szabo E, Hu H, Wong Q, Cheung AM, Walmsley SL.

HIV Clin Trials. 2017 Jan;18(1):28-38. doi: 10.1080/15284336.2016.1266074. Epub 2016 Dec 13.

PMID:
27951753
33.

Sequence diversity and associated pathogenicity of the hemagglutinin cleavage site of H5N2 avian influenza viruses isolated from chickens in Taiwan during 2013-2015.

Li KP, Chang PC, Cheng MC, Tan DH, Chen LH, Liu YP, Lin YJ, Tsai HJ, Shien JH.

J Vet Med Sci. 2017 Jan 20;79(1):108-114. doi: 10.1292/jvms.16-0356. Epub 2016 Oct 3.

34.

Optimizing HIV pre-exposure prophylaxis implementation among men who have sex with men in a large urban centre: a dynamic modelling study.

MacFadden DR, Tan DH, Mishra S.

J Int AIDS Soc. 2016 Sep 23;19(1):20791. doi: 10.7448/IAS.19.1.20791. eCollection 2016.

35.

The Fimbrial Protein is a Virulence Factor and Potential Vaccine Antigen of Avibacterium paragallinarum.

Liu CC, Ou SC, Tan DH, Hsieh MK, Shien JH, Chang PC.

Avian Dis. 2016 Sep;60(3):649-55. doi: 10.1637/11410-031316-Reg.1.

PMID:
27610725
36.

Oxidative Difunctionalization of Alkenyl MIDA Boronates: A Versatile Platform for Halogenated and Trifluoromethylated α-Boryl Ketones.

Lv WX, Zeng YF, Li Q, Chen Y, Tan DH, Yang L, Wang H.

Angew Chem Int Ed Engl. 2016 Aug 16;55(34):10069-73. doi: 10.1002/anie.201604898. Epub 2016 Jul 22.

PMID:
27443890
37.

Use of an HIV-risk screening tool to identify optimal candidates for PrEP scale-up among men who have sex with men in Toronto, Canada: disconnect between objective and subjective HIV risk.

Wilton J, Kain T, Fowler S, Hart TA, Grennan T, Maxwell J, Tan DH.

J Int AIDS Soc. 2016 Jun 3;19(1):20777. doi: 10.7448/IAS.19.1.20777. eCollection 2016.

38.

Serosorting and recreational drug use are risk factors for diagnosis of genital infection with chlamydia and gonorrhoea among HIV-positive men who have sex with men: results from a clinical cohort in Ontario, Canada.

Grewal R, Allen VG, Gardner S, Moravan V, Tan DH, Raboud J, Bayoumi AM, Kaul R, Mazzulli T, McGee F, Rourke SB, Burchell AN; OHTN Cohort Study Research Team.

Sex Transm Infect. 2017 Feb;93(1):71-75. doi: 10.1136/sextrans-2015-052500. Epub 2016 May 6.

39.

Memory for recently accessed visual attributes.

Jiang YV, Shupe JM, Swallow KM, Tan DH.

J Exp Psychol Learn Mem Cogn. 2016 Aug;42(8):1331-7. doi: 10.1037/xlm0000231. Epub 2016 Feb 4.

PMID:
26844575
40.

Enhanced syphilis screening among HIV-positive men (ESSAHM): a study protocol for a clinic-randomized trial with stepped wedge design.

Burchell AN, Allen VG, Grewal R, MacPherson PA, Rachlis A, Walmsley S, Mishra S, Gardner SL, Raboud J, Cooper C, Gough K, Rourke SB, Rousseau R, Salit I, Tan DH.

Implement Sci. 2016 Jan 16;11:8. doi: 10.1186/s13012-016-0371-0.

41.

Effect of Intercurrent Infections and Vaccinations on Immune and Inflammatory Biomarkers Among Human Immunodeficiency Virus-Infected Adults on Suppressive Antiretroviral Therapy.

Tan DH, Szadkowski L, Raboud J, Yi TJ, Shannon B, Kaul R, Liles WC, Walmsley S.

Open Forum Infect Dis. 2015 Mar 9;2(2):ofv036. doi: 10.1093/ofid/ofv036. eCollection 2015 Apr.

42.

Loss of the Capsule Increases the Adherence Activity but Decreases the Virulence of Avibacterium paragallinarum.

Tu TY, Hsieh MK, Tan DH, Ou SC, Shien JH, Yen TY, Chang PC.

Avian Dis. 2015 Mar;59(1):87-93.

PMID:
26292540
43.

High incidence of diagnosis with syphilis co-infection among men who have sex with men in an HIV cohort in Ontario, Canada.

Burchell AN, Allen VG, Gardner SL, Moravan V, Tan DH, Grewal R, Raboud J, Bayoumi AM, Kaul R, Mazzulli T, McGee F, Rourke SB; OHTN Cohort Study Team.

BMC Infect Dis. 2015 Aug 20;15:356. doi: 10.1186/s12879-015-1098-2.

44.

Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis.

Yoong D, Naccarato M, Sharma M, Wilton J, Senn H, Tan DH.

Int J STD AIDS. 2016 Jul;27(8):608-16. doi: 10.1177/0956462415589896. Epub 2015 May 29.

PMID:
26025254
45.

Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review.

Wilton J, Senn H, Sharma M, Tan DH.

HIV AIDS (Auckl). 2015 Apr 28;7:125-36. doi: 10.2147/HIV.S50025. eCollection 2015. Review.

46.

The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort study.

Klein MB, Young J, Dunn D, Ledergerber B, Sabin C, Cozzi-Lepri A, Dabis F, Harrigan R, Tan DH, Walmsley S, Gill J, Cooper C, Scherrer AU, Mocroft A, Hogg RS, Smaill F; Canadian−European Clade Collaboration.

CMAJ Open. 2014 Oct 1;2(4):E318-29. doi: 10.9778/cmajo.20140017. eCollection 2014 Oct.

47.

The haemagglutinin of Avibacterium paragallinarum is a trimeric autotransporter adhesin that confers haemagglutination, cell adherence and biofilm formation activities.

Wang YP, Hsieh MK, Tan DH, Shien JH, Ou SC, Chen CF, Chang PC.

Vet Microbiol. 2014 Dec 5;174(3-4):474-482. doi: 10.1016/j.vetmic.2014.10.013. Epub 2014 Oct 25.

PMID:
25465664
48.

Mild rhodium(III)-catalyzed C-H allylation with 4-vinyl-1,3-dioxolan-2-ones: direct and stereoselective synthesis of (E)-allylic alcohols.

Zhang SS, Wu JQ, Lao YX, Liu XG, Liu Y, Lv WX, Tan DH, Zeng YF, Wang H.

Org Lett. 2014 Dec 19;16(24):6412-5. doi: 10.1021/ol503229c. Epub 2014 Dec 1.

PMID:
25438098
49.

Herpes simplex virus type 2 serostatus is not associated with inflammatory or metabolic markers in antiretroviral therapy-treated HIV.

Tan DH, Raboud JM, Szadkowski L, Yi TJ, Shannon B, Kaul R, Liles WC, Walmsley SL.

AIDS Res Hum Retroviruses. 2015 Mar;31(3):276-81. doi: 10.1089/AID.2014.0183. Epub 2014 Dec 17.

50.

Acceptability of bone antiresorptive therapy among HIV-infected adults at different stages of antiretroviral therapy.

Taras J, Arbess G, Owen J, Guiang CB, Tan DH.

Patient Prefer Adherence. 2014 Sep 24;8:1311-6. doi: 10.2147/PPA.S67090. eCollection 2014.

Supplemental Content

Support Center